Helsinn_Corporate_1

Building better todays for people with cancer

As a world leading cancer care company we aim to improve the health and quality of life for every person with cancer – today, now, when it counts.

 

At Helsinn, our vision is to help people with cancer get the most of every day. As one of the world’s leading cancer care companies, our goal is to make everything we do, from the products we choose to license to the exacting standards we apply to manufacturing, count towards improving the lives of people with cancer.

Helsinn_Corporate_2

Building better todays for people with cancer

As a world leading cancer care company we aim to improve the health and quality of life for every person with cancer – today, now, when it counts.

 

At Helsinn, our vision is to help people with cancer get the most of every day. As one of the world’s leading cancer care companies, our goal is to make everything we do, from the products we choose to license to the exacting standards we apply to manufacturing, count towards improving the lives of people with cancer.

Helsinn_Corporate_3

Building better todays for people with cancer

As a world leading cancer care company we aim to improve the health and quality of life for every person with cancer – today, now, when it counts.

 

At Helsinn, our vision is to help people with cancer get the most of every day. As one of the world’s leading cancer care companies, our goal is to make everything we do, from the products we choose to license to the exacting standards we apply to manufacturing, count towards improving the lives of people with cancer.

Helsinn_Corporate_4

Building better todays for people with cancer

As a world leading cancer care company we aim to improve the health and quality of life for every person with cancer – today, now, when it counts.

 

At Helsinn, our vision is to help people with cancer get the most of every day. As one of the world’s leading cancer care companies, our goal is to make everything we do, from the products we choose to license to the exacting standards we apply to manufacturing, count towards improving the lives of people with cancer.

 
 

Anamorelin Phase III Data

Cancer Anorexia-Cachexia Syndrome

Helsinn group to present pivotal phase III trial data from the Romana 1 & 2 studies at this year's European Society of Medical Oncology conference (Madrid, Spain)
Saturday 27th September 2014 at 14:00 (CET)
Anamorelin Phase III Data
 
 

Invitation to attend

The Helsinn Annual CYTO/HPAPI Symposium & Manufacturing  VIP Facilities Tour

Biasca (Switzerland) - Friday 10th October 2014 Invitation to attend

NEWS

Are you a healthcare professional?
Yes
No